Finerenone is a non-steroidal mineralocorticoid receptor antagonist used as an active pharmaceutical ingredient. It is supplied as a pharmaceutical raw material for the manufacturing of medications indicated to reduce the risk of kidney function decline, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes, as well as for heart failure with reduced ejection fraction.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1050477-27-4
4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid
pharmaceutical intermediate for finerenone
(S)-4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic Acid
Pharmaceutical intermediate for finerenone
(4R)-4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-1,6-naphthyridine-3-carboxylic acid
n.a
5-Desethoxy,-5-Methoxy-Finerenone
Mineralocorticoid receptor antagonist intermediate
돌루테그라비르
HIV-1 integrase inhibitor
DOLUTEGRAVIR SODIUM
active pharmaceutical ingredient
7-methyl-2-(2,2,3,3-tetradeuteriocyclopropyl)-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
active pharmaceutical ingredient
Tetrabutylammonium acetate
Phase transfer catalyst
4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide
BTBHLEZXCOBLCY-UHFFFAOYSA-N
CCOC1=NC=C(C2=C1C(C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C